SCHEMBL29290973

SCHEMBL29290973

Cc1c(-c2nsc(CN3CCCC3)n2)c2cccc(Cl)c2n1C1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.60
KCNH2 Q12809 2/20 0.42
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29290979 0.80 CNR1 (0.52) CNR1KCNH2
SCHEMBL27667942 0.79 CNR1 (0.46) CNR1CNR2
SCHEMBL29290978 0.79 CNR1 (0.53) CNR1KCNH2
SCHEMBL3568197 0.75 CNR1 (1.00) CNR1KCNH2CNR2
SCHEMBL29290975 0.75 CNR1 (0.46) CNR1KCNH2CNR2
SCHEMBL3175835 0.68 CNR1 (0.85) CNR1KCNH2CNR2
SCHEMBL3562604 0.66 CNR1 (0.81) CNR1KCNH2CNR2
SCHEMBL3188793 0.66 CNR1 (0.87) CNR1KCNH2CNR2
SCHEMBL3180193 0.66 CNR1 (0.80) CNR1KCNH2CNR2
SCHEMBL27667927 0.66 CNR1 (0.36) CNR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689045-A Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness 因美制药公司 2019-04-26 CN claimed
CN-109689045-A Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness 因美制药公司 2019-04-26 CN disclosed